Method of treating diabetes type 2 by administering ultrarapid acting insulin

Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.

Saved in:
Bibliographic Details
Main Authors POTOCKA ELIZABETH, BAUGHMAN ROBERT A, BOSS ANDERS HASAGER, RICHARDSON PETER, PETRUCCI RICHARD
Format Patent
LanguageEnglish
Published 07.01.2014
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Bibliography:Application Number: US201213351855